161Tb-DOTATOC

N/A

Report date: 2025/11/20 16:01:08

NME

Base Information

Drug Name161Tb-DOTATOC

Drug Alias NameN/A

ClassificationRadiation-emitting products > Nuclides > Terbium > 161TbRadiation-emitting products > Radioactive therapeutic agentRadiation-emitting products > Radionuclide Drug Conjugates +[4]

Mechanisms of ActionSomatostatin receptor binders

TargetsSomatostatin receptor

Therapy Area/IndicationsParagangliomaNeuroendocrine Tumors

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryGermany

CombinationsNo

Global Highest StatusClinical

Highest Status in ChinaN/A

Originator CompaniesZentralklinik Bad Berka

China Registration ClassN/A

Develop Information

Active CompaniesZentralklinik Bad Berka

Inactive CompaniesN/A

Active IndicationsParagangliomaNeuroendocrine Tumors

Inactive IndicationsN/A

Other Information

ATC CodeN/A